Showing results (41-50 of 318) with videos related to
Sort By:
Pageof 32
Diabetes|January 19, 2024
Mitochondrial Dynamics, Diabetes, and Cardiovascular DiseaseLuis Miguel García-Peña, E Dale Abel, Renata O PereiraCirculation Research|June 4, 2026
Adipose Tissue Plasticity, Lipoprotein Metabolism, and Cardiovascular Risk: The Emerging Role of the GLP-1 AxisGiuliana G Repetti, E Dale Abel, Peter Tontonoz, et al.Free Radical Biology & Medicine|April 28, 2021
Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathyNikole J Byrne, Namakkal S Rajasekaran, E Dale Abel, et al.Endocrinology|May 3, 2008
Captopril normalizes insulin signaling and insulin-regulated substrate metabolism in obese (ob/ob) mouse heartsImene Tabbi-Anneni, Jonathan Buchanan, Robert C Cooksey, et al.Circulation Research|April 4, 2009
Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressureJ David Symons, Shawna L McMillin, Christian Riehle, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|June 24, 2003
Improved coronary vascular function evoked by high-intensity treadmill training is maintained in arteries exposed to ischemia and reperfusionJ David Symons, Yoko Hayashi, Jodi L EnsunsaAmerican Journal of Physiology. Renal Physiology|July 19, 2018
Soluble (pro)renin receptor as a potential therapy for diabetes insipidusKevin T Yang, Tianxin Yang, J David SymonsPharmaceuticals (Basel, Switzerland)|October 8, 2016
Quercetin: A Treatment for Hypertension?-A Review of Efficacy and MechanismsAbigail J Larson, J David Symons, Thunder JaliliAdvances in Nutrition (Bethesda, Md.)|February 15, 2012
Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanismsAbigail J Larson, J David Symons, Thunder JaliliIEEE Transactions on Nanobioscience|August 7, 2023
Plasmonic Optical Fiber Based Continuous in-Vivo Glucose Monitoring for ICU/CCU SetupSouvik Kundu, Shawana Tabassum, Ritwesh A Kumar, et al.Pageof 32